Catalent Inc (NYSE:CTLT)
$ 55.61 0.09 (0.16%) Market Cap: 10.06 Bil Enterprise Value: 14.88 Bil PE Ratio: 0 PB Ratio: 2.79 GF Score: 81/100

Catalent Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 02:00PM GMT
Release Date Price: $78.55 (+2.32%)
Daniel Gregory Brennan;John R. Chiminski
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences;Catalent, Inc. - Chairman & CEO

Good morning. This is Dan Brennan. UBS' pharma services, tools diagnostics analyst. Welcome to Day 3 here of UBS Global Health Care Conference, 10:00 slot. Really pleased to be joined here with the Chairman and CEO of Catalent, John Chiminski. I believe Paul Surdez is also on the phone. He's Head of IR there. While this is virtual, hopefully, this has been a really effective use of everyone's time and really looking forward to getting into the discussion. Please feel free to go on to the webcast, send questions through that. I see it real-time on my screen. And hopefully, I can kind of get those questions posed during the Q&A session.

So first, with that, John, welcome, and thank you for joining, obviously. And I thought the most productive way to start this would be to have you make some opening comments and kind of put us in the direction that you want to lead us. So thanks again.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot